Bronze
EzDiatech Inc. is a specialized IVD medical device company that provides fast, precise and multiplexed diagnoses.
VEUPLEX™ TBI assay, which is designated of Innovative Medical Device by the Korean Ministry of Food and Drug Safety, is intended to be used for quantitative detection of multiple biochemical markers named GFAP (Glial fibrillary acidic protein, hereinafter GFAP) and UCHL1 (Ubiquitin carboxyl- terminal hydrolase L1, hereinafter UCH-L1) in the serum of patients suspected of traumatic brain injury (intracranial injury), and a semiquantitative interpretation of test results, using the fluorescence immunoassay method in order to monitor the patients before/without a neuroimaging radiological scan following head injury. The VEUPLEX™ TBI (Traumatic Brain Injury) assay has more than 94% sensitivity and more than 98% specificity, so the VEUPLEX™ TBI (Traumatic Brain Injury) assay can provide high accuracy (over 95%) for diagnosing traumatic brain injuries including mild TBI (Traumatic Brain Injury). Using the VEUPLEX™ TBI (Traumatic Brain Injury) assay, you can diagnose (mild) traumatic brain injuries accurately and fast within 40~50 minutes depending on the number of samples by quantitatively detecting the biomarkers early.